1Ajani J A, Ilson D H, Dangherty K, et al. Activity of taxol in patients with sqamous cell carcinoma and adenocarcinoma of the esophagus[J]. J Natl Cancer Inst, 1994, 86(4) : 1086.
2Ajani J A. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentay[J]. Semin Oncol, 1994, 21(4): 474.
3Ilson D H, Ajani J, Bhalla K, et al. Phase Ⅱ trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus[J]. J Clin Oncol, 1998, 16(5) : 1826.
1P. Fumoleau,B. Chevallier,P. Kerbrat,V. Dieras,N. Azli,M. Bayssas,M. Glabbeke. Current status of Taxotere? (docetaxel) as a new treatment in breast cancer[J] 1995,Breast Cancer Research and Treatment(1):39～46
2Fujita Y,Hiramatsu M,Kawai M.Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil:a retrospective study[J].Diseases of the Esophagus,2008,21(6):496.
3Heath E I,Urba S,Marshall J,et al.Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus[J].Invest New Drugs,2002,20(1):95.
4Muro K,Hamaguchi T,Ohtsu A,et al.A phase Ⅱ study of single-agent docetaxel in patients with metastatic esophageal cancer[J].Ann Oncol,2004,15 (6):955.
